Home > Healthcare > Medical Devices > Diagnostic Devices > Thrombosis and Hemostasis Biomarkers Market

Thrombosis and Hemostasis Biomarkers Market Trends

Report ID: GMI12202
Published Date: Nov 2024
Report Format: PDF

Download Free Sample

Thrombosis and Hemostasis Biomarkers Market Trends

Technological advancements in biomarker testing are significantly propelling growth in the market. Cutting-edge technologies, such as high-sensitivity immunoassays, next-generation sequencing (NGS), and digital PCR, are enabling the highly accurate detection of thrombosis- and hemostasis-related biomarkers, providing deeper insights into disease mechanisms and patient-specific risk factors. Enhanced analytical platforms, such as multiplex assays and automated coagulation analyzers, streamline workflows in clinical laboratories, improving both diagnostic speed and reliability.

Moreover, advances in point-of-care testing devices allow for rapid, on-site biomarker assessment, which is vital for emergency scenarios like stroke or pulmonary embolism. Additionally, non-invasive biomarker testing methods are becoming more prevalent, enabling continuous patient monitoring with minimal discomfort. Collectively, these innovations are driving improved patient outcomes, personalized therapies, and more efficient healthcare delivery.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global thrombosis and hemostasis biomarkers industry was valued at USD 5.2 billion in 2023 and is estimated to grow at a CAGR of over 5.8% from 2024 to 2032, driven by rising incidences of cardiovascular and clotting disorders.

The reagents and consumables segment dominated the market with USD 3.3 billion in 2023 due to their pivotal role in diagnostic and research applications, including assay kits, chemicals, buffers, and other essential reagents.

The U.S. thrombosis and hemostasis biomarkers market is expected to grow at a 5.8% CAGR, reaching USD 3 billion by 2032, driven by high rates of cardiovascular disease.

Major players in the industry include Abbott Laboratories, ARUP Laboratories, Biomedica Diagnostics, BioMerieux, Cincinnati Children's Hospital Medical Center, Cleveland Clinic Laboratories, Diazyme Laboratories, F. Hoffmann-La Roche, HORIBA, Mayo Clinic Laboratories, and QuidelOrtho.